metformin has been researched along with beta-endorphin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CJ; Cheng, JT; Huang, CC; Liu, IM; Tzeng, TF | 1 |
Cheng, JT; Ou, HY; Wu, TJ; Yu, EH | 1 |
Chen, W; Cheng, JT; Lee, JP; Lin, KC; Wu, HT | 1 |
Berent-Spillson, A; Eyvazaddeh, AD; Love, T; Padmanabhan, V; Pennington, KP; Persad, CC; Pop-Busui, R; Smith, YR; Sowers, M; Zubieta, JK | 1 |
1 trial(s) available for metformin and beta-endorphin
Article | Year |
---|---|
Metformin increases insulin sensitivity and plasma beta-endorphin in human subjects.
Topics: Adult; beta-Endorphin; Blood Glucose; C-Reactive Protein; Cholesterol, HDL; Dose-Response Relationship, Drug; Fasting; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Metformin; Middle Aged | 2006 |
3 other study(ies) available for metformin and beta-endorphin
Article | Year |
---|---|
Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats.
Topics: Adrenalectomy; Animals; beta-Endorphin; Blood Glucose; Diabetes Mellitus, Experimental; Glucose Transporter Type 4; Hypoglycemic Agents; Male; Metformin; Mice; Naloxone; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Wistar; Streptozocin | 2006 |
Metformin can activate imidazoline I-2 receptors to lower plasma glucose in type 1-like diabetic rats.
Topics: Animals; beta-Endorphin; Blood Glucose; Diabetes Mellitus, Type 1; Disease Models, Animal; Humans; Hypoglycemic Agents; Imidazoline Receptors; Male; Metformin; Rats; Rats, Wistar | 2011 |
Insulin resistance influences central opioid activity in polycystic ovary syndrome.
Topics: Adult; beta-Endorphin; Binding Sites; Brain; Carbon Radioisotopes; Case-Control Studies; Female; Fentanyl; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Magnetic Resonance Imaging; Metformin; Michigan; Pilot Projects; Polycystic Ovary Syndrome; Positron-Emission Tomography; Receptors, Opioid, mu; Time Factors; Treatment Outcome; Young Adult | 2011 |